BOEHRINGER-INGELHEIM
Boehringer Ingelheim announced today that Cowtribe is the first recipient of investment and non-financial support from the Boehringer Ingelheim Social Engagement (BI SE) initiative, a program which aims to close a critical financing gap for social businesses in vulnerable communities.
Cowtribe, a leading last-mile veterinary delivery company from Ghana, leverages technology to help coordinate deliveries of veterinary vaccines and other animal health products to rural and underserved communities, where many farmers are dependent on just a few animals.
With innovative solutions, such as software supported demand & supply matching, as well as a partnership for drone delivery, Cowtribe bridges the final, critical last mile to get animal medication and veterinary vaccines to smallholder farmers in remote areas. The social start-up, which was founded in 2017, plans to expand to other African markets and collaborates with the government of Ghana on a national livestock identification system, based on Cowtribe’s market data and network.
Start-ups often need more than just funding. BI SE was launched in 2021 to provide investment and non-financial support, together with complementary partners and by engaging Boehringer Ingelheim’s employees to help scale up solutions of social businesses to create systemic change.
BI SE underlines Boehringer Ingelheim’s commitment to find innovative financing solutions with the intention to scale social impact. It complements Boehringer Ingelheim’s flagship initiative, Making More Health, which has committed to positively impact the lives and health of 50 million people through supporting social entrepreneurs in vulnerable communities.
“We are delighted to grant the first investment of Boehringer Ingelheim Social Engagements to Cowtribe,” said Ilka Wicke, Global Head of Making More Health at Boehringer Ingelheim. “Every year smallholder farmers lose about 25 percent of their livestock, due to preventable diseases. Cowtribe is at the forefront of addressing this problem by transforming the critical last-mile distribution in Africa. Their smart logistics platform, based on demand optimization, combined with innovative drone delivery concepts, helps secure the availability and accessibility of vaccines for smallholder farmers. Together, we can significantly improve the lives of many farmers across Africa.”
“In Africa, there are over 200 million smallholder farmers without access to reliable animal health services. We are incredibly excited to partner with BI SE to support our mission to make access to animal vaccines in Africa a right, not a privilege,” added Peter Awin, co-founder and CEO of Cowtribe. “This funding will be used to accelerate our growth in Ghana. This will involve entering new communities and building robust tech capabilities, product development, and attracting new talent.”
Financial details will not be disclosed. The news was announced during the “Making More Health Together 2022" convention, a two-day hybrid event, which focuses on the empowerment of social entrepreneurship and topics relevant to human and animal health, as well as social innovation.
Click here for the full release: https://www.boehringer-ingelheim.com/investment-social-engagements-cowtribe-veterinary-startup
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005338/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SymphonyAI and AML Intelligence Launch FinCrime Frontier 2025–26 Report: Proactive Intelligence Becomes Compliance’s Next Competitive Edge11.11.2025 10:00:00 CET | Press release
Survey of 250+ global compliance leaders reveals nearly 80% plan to innovate with AI-powered proactive intelligence, but cost and data hurdles stand in the way SymphonyAI, a global leader in vertical AI product platforms, and AML Intelligence, the leading source of news and insight for the financial crime compliance community, today released the FinCrime Frontier 2025–26 Report. The landmark study defies conventional industry narratives: rather than seeing evolving compliance expectations as a burden, a majority of financial institutions now cite them as the primary opportunity and catalyst for modernization. A sector ready for transformation - if it can break through real dependencies Insights from over 250 compliance, risk, and financial crime leaders show a pivotal mindset shift. Instead of bracing for disruption, 58% of institutions say today’s fast-changing environment is the push they need to invest in proactive intelligence and smarter, data-driven operations. Ambition is high:
Infobip Predicts Record 3.9 Billion Brand Messages This Shopping Season as RCS Surges 269%11.11.2025 10:00:00 CET | Press release
RCS set to be the fastest growing communications channel this Black Friday and Cyber Monday Global communications platform Infobip forecasts over 3.9 billion messages exchanged between brands and customers this shopping season, marking a 15% increase year on year. This reflects how AI, mobile commerce, and rich messaging channels are powering more personalized shopping experiences. Rich Communication Services (RCS) will be the fastest-growing channel in 2025, with volumes rising 161% on Black Friday and 269% on Cyber Monday worldwide. SMS remains the leading retail channel with nearly 2.7 billion interactions. In the US, more than 1.9 billion SMS messages are expected, while RCS volumes surge to over 57 million, a dramatic increase from 2024. WhatsApp engagement is up 44%, and email volumes rise more than 50% on Cyber Monday. US consumers surveyed by Infobip plan to spend mainly between $250 and $1,000 on Black Friday. Across Europe, RCS volumes are expected to grow more than sixfold o
Qorium Secures €22m Investment to Accelerate Cultivated Leather Commercialisation11.11.2025 09:00:00 CET | Press release
Invest-NL, LIOF and several private investors join Brightlands Venture Partners and Sofinnova Partners in supporting the Dutch biotech firm’s growth Qorium, the Dutch biotechnology company pioneering cultivated leather, today announced it has secured a €22 million investment from Invest-NL and LIOF alongside existing investors Brightlands Venture Partners and Sofinnova Partners. An influential group of high net worth individuals have also participated in the round while the Invest-NL investment is made under the InvestEU guarantee scheme of the European Commission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251111669534/en/ Qorium is successfully producing sustainable real leather The cultivated leather market is projected to grow rapidly as demand increases for consistent and high-quality real leather. Qorium’s technology produces beautiful, uniform real leather from a few animal cells, eliminating the need for livestoc
GigaDevice Partners With Melchioni Electronics to Expand Business in France, Italy and the Iberian Peninsula11.11.2025 08:00:00 CET | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, has entered into a distribution agreement with Milan-based Melchioni Electronics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110615465/en/ The partnership extends GigaDevice's reach into several major European markets, with Melchioni Electronics supplying not only GigaDevice's leading Flash and MCU lines but also delivering dedicated field application engineering support. The deal covers distribution in France, Italy, Spain and Portugal, with on-the-ground presence in each of these countries. GigaDevice delivers world-class SPI NOR Flash, SLC NAND Flash, 32-bit microcontrollers, analog, and sensor products. These technologies play a pivotal role across applications, including industrial automation, automotive, consumer electronics, IoT, network communications, mobile, and PCs. "The es
Aqemia to Participate in the Jefferies Global Healthcare Conference 202511.11.2025 08:00:00 CET | Press release
Aqemia, a pioneering TechBio company combining generative AI and quantum-inspired physics to invent drugs, announces that Maximilien Levesque, CEO and co-founder, and Théa Vu-Bignand, VP Finance, will attend the Jefferies Global Healthcare Conference, taking place in London from November 17 – 20, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251116540648/en/ With its physics-based generative AI platform for therapeutic molecule invention, QEMI, Aqemia can design novel drug candidates in a repeatable, frugal, and scalable way, with the ambition to deliver new therapies faster to patients who currently lack effective treatments, particularly in oncology. In this perspective, Aqemia remains focused on building value through its internal preclinical pipeline while forging partnerships that validate its platform and scientific edge. About Aqemia Aqemia is a drug invention company dedicated to creating novel molecules to ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
